ロード中...
Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells
Resistance to chemotherapy and a high relapse rate highlight the importance of finding new therapeutic options for the treatment of acute myeloid leukemia (AML). Histone deacetylase (HDAC) inhibitors (HDACIs) are a promising class of drugs for the treatment of AML. HDACIs have limited single-agent c...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351634/ https://ncbi.nlm.nih.gov/pubmed/28030834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14062 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|